Evaluating the mychoiceTM tool for cancer patients
mychoiceTM Implementation in a Real World Clinical Environment - Delivery and Effectiveness
This study tests whether the mychoiceTM tool can help new cancer patients feel more comfortable discussing clinical trials with their doctors.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fox Chase Cancer Center Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Trial ID | NCT06222242 on ClinicalTrials.gov |
What this trial studies
This evaluation focuses on the feasibility and acceptability of the mychoiceTM tool for new Medical Oncology patients. It aims to enhance discussions between patients and their providers regarding clinical trials as a treatment option. Patients will receive a link to the mychoiceTM tool and complete a short survey about their experience. The study will follow up with patients who agree to participate further to assess the tool's impact on their preparedness to discuss clinical trials.
Who should consider this trial
Good fit: Ideal candidates are English-speaking adults over 18 years old who have recently had their first Medical Oncology appointment.
Not a fit: Patients who do not have a cancer diagnosis or cannot speak or read English may not benefit from this study.
Why it matters
Potential benefit: If successful, this could empower cancer patients to make informed decisions about participating in clinical trials.
How similar studies have performed: While the approach of using a tool to facilitate discussions about clinical trials is not widely tested, similar initiatives have shown promise in enhancing patient engagement.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 18 years of age or over Able to speak and read English Medical Oncology patients who have had their initial visit Have a cell phone number and/or an email in the electronic medical record Exclusion Criteria Doesn't not speak or read English Patients who do not have a cancer diagnosis
Where this trial is running
Philadelphia, Pennsylvania
- Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Linda Fleisher, PhD, MPH — Fox Chase Cancer Center
- Study coordinator: Linda Fleisher, PhD, MPH
- Email: linda.fleisher@fccc.edu
- Phone: (215) 728-4066
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.